Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **physical barrier of the skin and gut mucosa** consists of highly organized epithelial structures—most prominently the stratum corneum in skin and the mucosal epithelial layer in the gut—which serve as key protective interfaces between the body and the external environment. In skin, the barrier is formed primarily by the outermost epidermal layer, the stratum corneum, which acts as a 'brick-and-mortar' structure where protein-rich corneocytes (bricks) are sealed by extracellular lipids (mortar) such as ceramides, cholesterol, and fatty acids. This barrier limits pathogen invasion, chemical exposure, water loss, and mechanical damage, and supports immune defense, pH maintenance, and normal skin microbiome composition[1][2][3][4][5]. Similar physical barriers exist in the gut, where mucosal epithelia and overlying mucus protect underlying tissues from microorganisms, toxins, and digestive enzymes. While often referred to in therapeutic contexts (e.g., in barrier repair creams or as a general concept in disease), the physical barrier itself is not a discrete molecular target (such as a single protein or receptor), but a highly integrated structure composed of various cell types and biochemical components. Thus, it is not considered a classical drug target like a receptor or enzyme. Common diseases of barrier dysfunction include atopic dermatitis, other inflammatory skin diseases, and gut inflammatory disorders. Direct repair of this barrier is often achieved through topical application of creams containing lipids or occlusive agents that restore the physical and biochemical integrity of the barrier. Note: "Physical barrier on skin/gut mucosa" is a functional/structural concept and not a single molecule or receptor, so it is not considered a classical therapeutic target. For molecular targets within these barriers (such as filaggrin, ceramides, or tight junction proteins), more specific names should be used[2][3][4].
Physical protection; Enhancement or restoration of lipid matrix; Moisture retention; Reduction of transepidermal water loss (TEWL)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physical barrier of skin and gut mucosa.